Safety and tolerability of high-dose intravenous esomeprazole for prevention of peptic ulcer rebleeding

被引：0
|
作者：
Ernst J. Kuipers
Joseph J. Y. Sung
Alan Barkun
Joachim Mössner
Dennis Jensen
Robert Stuart
James Y. W. Lau
Henrik Ahlbom
Tore Lind
Jan Kilhamn
机构：
[1] Erasmus MC University Medical Center,Departments of Gastroenterology and Hepatology, and Internal Medicine
[2] Chinese University of Hong Kong,Institute of Digestive Diseases
[3] McGill University,Division of Gastroenterology
[4] Universitätsklinikum Leipzig,Medizinische Klinik und Poliklinik für Gastroenterologie und Rheumatologie
[5] David Geffen School of Medicine at UCLA and CURE: Digestive Diseases Research Center,undefined
[6] Glasgow Royal Infirmary,undefined
[7] AstraZeneca R&D,undefined
来源：
Advances in Therapy | 2011年 / 28卷
关键词：
esomeprazole; intravenous; mortality; peptic ulcer; rebleeding; safety; tolerability;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：150 / 159
页数：9
相关论文
共 50 条
  • [1] Safety and tolerability of high-dose intravenous esomeprazole for prevention of peptic ulcer rebleeding
    Kuipers, Ernst J.
    Sung, Joseph J. Y.
    Barkun, Alan
    Moessner, Joachim
    Jensen, Dennis
    Stuart, Robert
    Lau, James Y. W.
    Ahlbom, Henrik
    Lind, Tore
    Kilhamn, Jan
    [J]. ADVANCES IN THERAPY, 2011, 28 (02) : 150 - 159
  • [2] Cost Effectiveness of High-Dose Intravenous Esomeprazole for Peptic Ulcer Bleeding
    Barkun, Alan N.
    Adam, Viviane
    Sung, Joseph J. Y.
    Kuipers, Ernst J.
    Moessner, Joachim
    Jensen, Dennis
    Stuart, Robert
    Lau, James Y.
    Naucler, Emma
    Kilhamn, Jan
    Granstedt, Helena
    Liljas, Bengt
    Lind, Tore
    [J]. PHARMACOECONOMICS, 2010, 28 (03) : 217 - 230
  • [3] Cost Effectiveness of High-Dose Intravenous Esomeprazole for Peptic Ulcer Bleeding
    Alan N. Barkun
    Viviane Adam
    Joseph J. Y. Sung
    Ernst J. Kuipers
    Joachim Mössner
    Dennis Jensen
    Robert Stuart
    James Y. Lau
    Emma Nauclér
    Jan Kilhamn
    Helena Granstedt
    Bengt Liljas
    Tore Lind
    [J]. PharmacoEconomics, 2010, 28 : 217 - 230
  • [4] Intravenous Esomeprazole for Prevention of Peptic Ulcer Rebleeding: A Randomized Trial in Chinese Patients
    Yu Bai
    Dong-Feng Chen
    Rong-Quan Wang
    You-Xiang Chen
    Rui-Hua Shi
    De-An Tian
    Huifang Chen
    Stefan Eklund
    Zhao-Shen Li
    [J]. Advances in Therapy, 2015, 32 : 1160 - 1176
  • [5] Intravenous Esomeprazole for Prevention of Peptic Ulcer Rebleeding: A Randomized Trial in Chinese Patients
    Bai, Yu
    Chen, Dong-Feng
    Wang, Rong-Quan
    Chen, You-Xiang
    Shi, Rui-Hua
    Tian, De-An
    Chen, Huifang
    Eklund, Stefan
    Li, Zhao-Shen
    [J]. ADVANCES IN THERAPY, 2015, 32 (11) : 1160 - 1176
  • [6] Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding
    Alan B. R. Thomson
    [J]. Current Gastroenterology Reports, 2009, 11 (5) : 339 - 341
  • [7] The cost-effectiveness of high-dose intravenous esomeprazole in peptic ulcer bleeding -: a US cost perspective
    Barkun, Alan
    Adam, Vivian
    Sung, Joseph
    Kuipers, Ernst
    Mossner, Joachim
    Jensen, Dennis
    Stuart, Robert
    Lau, James
    Granstedt, Helena
    Lind, Tore
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S48 - S48
  • [8] Cost-effectiveness of high-dose intravenous esomeprazole in patients with peptic ulcer bleeding in the USA and Europe
    Brown, Ruth E.
    Nandi, Jyoti
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2010, 10 (04) : 371 - 374
  • [9] High-Dose Intravenous Proton Pump Inhibitors for Prevention of Recurrent Peptic Ulcer Bleeding in Chinese and Western Populations: Rebleeding Is Not Influenced by Ethnicity
    Lau, James Y.
    Sung, Joseph J. Y.
    Lind, Tore
    Persson, Tore
    Eklund, Stefan
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S210 - S210
  • [10] ULCER Prediction and prevention of peptic ulcer rebleeding
    Jensen, Dennis M.
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2012, 9 (01) : 7 - 8
12345